Obstructive Jaundice Clinical Trial
Official title:
A Multisite, Open-label, Prospective Cohort Study Investigating Huaier Granule Combined With Biliary Drainage for Treatment of Malignant Obstructive Jaundice(MOJ)
This study is designed to evaluate the efficacy and safety of the combination treatment of Huaier granule and biliary drainage for malignant obstructive jaundice.
After sign the informed consent, the, eligible patients are those who have completed the
examinations within 2 weeks after the biliary drainage will enter the study and visit the
study sites at Weeks 12, 24, 36, and 48. The follow-up duration is up to 48 weeks or until
the death of patient during the study. The patients will be allocated to two groups based on
whether being exposed to Huaier granule or not.
Study data will be collected prospectively, including the patients' baseline characteristics,
chemo-/radio-therapy history, previous Huaier granule treatment, laboratory tests, imaging
examinations, and various clinical endpoints including liver function, quality of life,
status of survival, and safety.
This is a non-interventional study in patient population in real world. Therefore, the
patients' treatment regimen will not be interfered, i.e., the patients will independently
decide whether to take Huaier granule or not based on the recommendation from the clinician
after the drainage. The patients will be allocated into different groups completely according
to their treatment at clinic in real world. During the study, only the study required data
and endpoints will be collected.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01506115 -
Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma
|
N/A | |
Completed |
NCT00409864 -
Endoscopic Versus Percutaneous Drainage For Hilar Block in Gall Bladder Cancer
|
N/A | |
Not yet recruiting |
NCT06093048 -
Endoscopic Retrograde Cholangiopancreatography In Patients Older Than 65Years Old With Obstructive Jaundice: Efficacy And Outcome
|
N/A | |
Completed |
NCT02468076 -
Radiofrequency Ablation for Biliopancreatic Malignancy
|
Phase 2 | |
Recruiting |
NCT02797665 -
Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids
|
N/A | |
Recruiting |
NCT01367821 -
Immune Function in Patients With Obstructive Jaundice
|
N/A | |
Recruiting |
NCT06456476 -
Patients With Obstructive Jaundice In Sohag University Hospital
|
||
Completed |
NCT04385147 -
Advanced Endoscopy During COVID-19
|
||
Completed |
NCT02166840 -
Metal or Plastic Stents to Relieve Obstruction of Obstructive Jaundice Prior to Resection of Periampullary Tumors.
|
Phase 2 | |
Completed |
NCT05155475 -
Endoscopic Ultrasound Evaluation of the Common Bile Duct in Patients With Obstructive Jaundice Due to Bilio-pancreatic Malignancies (ECCO Trial)
|
||
Recruiting |
NCT03133026 -
Cholangioscopic Assessment of Occluded Biliary Stent and Role of Biliary Radiofrequency Ablation
|
N/A | |
Recruiting |
NCT01438385 -
Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders
|
N/A | |
Completed |
NCT01191814 -
Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression
|
N/A | |
Recruiting |
NCT05246176 -
Ultrasonography as a Single Tool for Guided Percutaneous Transhepatic Biliary Drainage in Obstructive Jaundice
|
N/A | |
Recruiting |
NCT03977779 -
Evaluation of the Use of a Biodegradable Endoprothesis in the Prevention of Post-Endoscopic Retrograde CholoangioPancreatography Pancreatitis
|
N/A | |
Completed |
NCT04823832 -
Endoscopic Versus Percutaneous Biliary Drainage for Resectable Pancreatic Head Cancer
|
N/A | |
Completed |
NCT03376945 -
Application of n-3 Fatty to Patient of Jaundice
|
N/A | |
Completed |
NCT03510754 -
Endoscopic Ultrasound-guided Biliary Drainage for Malignant Biliary Obstruction After Failed ERCP
|
||
Not yet recruiting |
NCT01688375 -
The Effect of Ursodeoxycholic Acid in Liver Functional Restoration of Patients With Obstructive Jaundice
|
Phase 2 | |
Recruiting |
NCT05928286 -
Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice
|